Dr. Krakow's research focus is on developing safer, more effective cellular immunotherapies to treat patients whose cancer has relapsed after BMT. For example, in one trial she used donor T cells (immune cells) that have been genetically modified with receptors to target leukemia.
Seattle Cancer Care Alliance, Fred Hutchinson Research Center:
1354 Aloha St, Seattle, WA 98109, USA
Get the latest thought leadership on AML delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life
AML stories, AML clinical trials, AML 101 articles and events with AML
Thanks to our HealthTree Community for AML Sponsors: